PAGE COLLECTIONS -- CHECK THEM OUT!

Thursday, August 6, 2020

Hydroxychloroquine Fact Sheet Part 2: Not Only is HCQ Safe, but It's an Effective Treatment for the Wuhan Virus

See Part 1 of Liberty Counsel's Fact Sheet here. And now let's get to part 2, which makes the case for HCQ as an effective treatment for the Wuhan virus. As in the last post, I've included my comments in blue italics.
Hydroxychloroquine and COVID-19

With substantial evidence that HCQ is a safe treatment for COVID-19, it is time to turn attention to the second question: does HCQ relieve symptoms of COVID-19 and reduce the chance of dying from it? 

In a survey of 6,200 medical doctors from 30 different nations, the plurality responded that they found that hydroxychloroquine (HCQ) was the “most effective therapy amongst COVID-19 treaters from a list of 15 options.” viii They also explained the following:
• The three most commonly prescribed treatments were analgesics (56%), Azithromycin (41%), and Hydroxychloroquine (33%)  
• The two most common treatment regimens for Hydroxychloroquine were: 
o (38%) 400mg twice daily on day one; 400 mg daily for five days 
o (26%) 400mg twice daily on day one; 200mg twice daily for four days 
[Despite the medical facts showing the safety and effectiveness of HCQ used properly, two doctors, Anthony Fauci and Deborah Birx have spoken. Neither treats patients; nevertheless they have become the ringmasters of the Wuhan virus circus! And their pie-in-the-face antics now include telling us to wear goggles and to put on our masks even in our own homes. When will the circus audience recognize they are being conned by a couple of clowns? ] 


On July 30, 2020, the Swiss Policy Research (SPR) released the following updated findings: “US physicians reported an 84% decrease in hospitalization rates, a 50% decrease in mortality rates among already hospitalized patients (if treated early), and an improvement in the condition of patients often within hours” of using a specific treatment.” ix The treatments it recommended included the following medications: “Zinc (50mg to 100mg per day), Hydroxychloroquine (400mg per day), Quercetin (500mg to 1000mg per day), Azithromycin (up to 500mg per day), and Heparin (usual dosage).”

 The SPR found that “the alleged or actual negative results with hydroxychloroquine in some studies were based on delayed use (intensive care patients), excessive doses (up to 2400mg per day), manipulated data sets (the Surgisphere scandal), or ignored contraindications (e.g., favism or heart disease).” In addition, many medical resources state that patients with psoriasis are to avoid HCQ. [Read that paragraph again. Deaths from HCQ were due to 1) using HCQ too late. It's most effective when symptoms first appear, not when they are at death's door when almost nothing will help! And 2) In some studies, patients were given TOXIC DOSES. HCQ isn't like Vitamin C that is water soluble and excreted when not needed. HCQ can build up in the body to toxic levels if not carefully administered. In some studies the doses were so high, death was almost guaranteed. And 3) In some cases HCQ is contraindicated. In most situations and for most patients it's safe and effective when used early in the disease in a regimen with vitamins and antibiotics.]

In addition, the SPR quoted from the website https://c19study.com which is a frequently updated compilation of medical studies. It has more than 65 medical studies, with at least 40 of them peer-reviewed with extensive medical data regarding treatments of COVID-19. 

viii Sermo. Largest Statistically Significant Study by 6,200 Multi-Country Physicians on COVID-19 Uncovers Treatment Patterns and Puts Pandemic in Context. (2020, April 2). https://www.sermo.com/press-releases/largeststatistically-significant-study-by-6200-multi-country-physicians-on-covid-19-uncovers-treatment-patterns-andputs-pandemic-in-context

ix Swiss Policy Research. On the treatment of Covid-19. (Updated: 2020, July 30). https://swprs.org/on-thetreatment-of-covid-19/tps://swprs.org/on-the-treatment-of-covid-19/ 

No comments:

Post a Comment